Dr. Ellen Turner discusses with CEO Money host, Michael Yorba, the non-invasive and pain free benefits of treating skin cancer with Superficial Radio Therapy. With Dr. Turner’s two dermatology practice locations in the Dallas area, she knows that one in three Texans will develop skin cancer in their lifetime. Check out the video below or […]
Blog
Sensus Healthcare, Inc. Announces Closing of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 17, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it completed a public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. All of the shares were offered by Sensus. The shares are listed on The […]
Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 13, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share. Sensus has granted a 30-day option to purchase up to an additional […]
Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
BOCA RATON, Fla., Sept. 12, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole book-running manager for the offering. Sensus intends to use the net proceeds from the offering […]
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
BOCA RATON, Fla., Sept. 7, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, participated at the National Cancer Care Alliance (NCCA) Leadership Board and Practice Quarterly […]
Sensus Healthcare to Participate in Two Upcoming Investor Conferences
BOCA RATON, Fla., Aug. 27, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will participate at two investor conferences in September 2018, as follows: Annual B. […]
What You Should Know About Your Family’s History of Skin Cancer
Do you know your family’s history of skin cancer? If one or more of your parents, siblings, or children develop skin cancer, you have a higher risk of developing skin cancer than a person with no family history of the disease. In fact, according to Sun & Skin News, a Skin Cancer Foundation publication, about […]
Making Sense of the Link Between Skin Color and Skin Cancer
While those with lighter skin tones are generally the most at risk for skin cancer, anyone with any skin color can get skin cancer. Unfortunately, many patients are under the impression that those with darker skin are not at risk for skin cancer. “People who have darker skin tones often believe that they’re not at […]
Inc: 19 Ideas on How to Push Yourself to the Next Level
Inc. recently sat down with 19 successful founders and executives to discuss how they push themselves to the next level. When asked about his support system, CEO of Sensus Healthcare, Joe Sardano, said, “One maxim our team hangs onto is, ‘Who packs your parachute?’ This saying comes from an old story originated by a U.S. Navy […]
OWM Industry Spotlight: Joe Sardano
CEO, Chairman and Co-Founder of Sensus Healthcare, Joe Sardano, was recently interviewed for a feature in AAWC‘s research journal, Ostomy Wound Management (OWM). Read the full interview here.
Fall Clinical Dermatology Conference
Join Sensus Healthcare at the Fall Clinical Dermatology Conference in Las Vegas, NV October 18th – 21st, 2018. For tickets and more information click here.
Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth
Ships 21 systems including 12 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 2, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radio Therapy for Treating Non-Melanoma Skin Cancer and Keloids
SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements BOCA RATON, Fla., Aug. 2, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy […]
5CC in Barcelona
Join Sensus Healthcare at the 5-Continent-Congress (5CC) in Barcelona, Spain August 30th – September 2nd, 2018. For tickets and more information click here.
Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018
BOCA RATON, Fla., July 31, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, nonsurgical “Innovator of the Year” at the 2018 Aesthetic Awards, hosted by The Aesthetic […]
Sensus Healthcare CEO Receives “Innovator of the Year” Award at The Aesthetic Show 2018
Sensus Also Named Runner-Up “Company Innovator of the Year” BOCA RATON, Fla., July 31, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced that the Company’s CEO, Joe Sardano, has been named non-physician, […]
Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018
BOCA RATON, Fla., July 24, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, August 2, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]
Is Your Blood Pressure Medicine Increasing Your Risk of Skin Cancer?
A recent study published in the Journal of American Dermatology has suggested a link between a commonly prescribed blood pressure medicine and skin cancer. Researchers at the University of Southern Denmark found that one of the most popular medicines used worldwide in the treatment of hypertension, hydrochlorothiazide (HCTZ), raises the risk of skin cancer by […]
Dr. Kevin Schewe on Colorado’s Best – Non-Surgical Technology for Skin Cancer – Alliance Cancer Care at Red Rocks
Dr. Kevin Schewe the Radiation Oncologist and Medical Director at Alliance Cancer Care at Red Rocks discusses the dangers of UV rays, the different types of skin cancer and SRT with Colorado’s Best on FOX network Channel 2 and Channel 31 in Denver. Watch the video here.
Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology
SkinCure Provides Turnkey Solution for Sensus’ SRT-100 Vision™, Aimed at Dermatology Community BOCA RATON, Fla., July 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), today announced a strategic agreement focused on marketing the […]